Human Gingiva-Derived Mesenchymal Stem Cells Ameliorate Streptozoticin-induced T1DM in mice via Suppression of T effector cells and Up-regulating Treg Subsets

There is yet no cure for type 1 diabetes (T1DM) so far. A significant body of evidence has demonstrated that bone marrow-derived mesenchymal stem cells (BMSCs) showed great potential in controlling T1DM. But there exists much difficulty in using BMSCs as a clinical therapy. We here test whether a ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Zhou, Li, Dang, Junlong, Zhang, Ximei, Wang, Julie, Chen, Yanming, Liang, Jichao, Li, Dongqing, Ma, Jilin, Yuan, Jia, Chen, Weiwen, Zadeh, Homayoun H., Olsen, Nancy, Zheng, Song Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681565/
https://www.ncbi.nlm.nih.gov/pubmed/29127315
http://dx.doi.org/10.1038/s41598-017-14979-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681565/
https://www.ncbi.nlm.nih.gov/pubmed/29127315
http://dx.doi.org/10.1038/s41598-017-14979-5

Ejemplares similares